Publix Pharmacy is participating in the Medicare GLP-1 Bridge program, allowing eligible Medicare Part D beneficiaries to fill qualifying GLP-1 prescriptions for weight management at Publix locations.
The Centers for Medicare & Medicaid Services launched the program July 1, and it runs through Dec. 31, 2027. It covers GLP-1 medications prescribed solely for weight loss or weight management, with Foundayo, Wegovy in injection and tablet form, and Zepbound KwikPen currently available through the program at Publix. Customers who are not eligible for the Bridge program may still access covered GLP-1 prescriptions through their Medicare Part D plan.
The move follows similar steps by other grocery pharmacies. Hy-Vee joined the Bridge program earlier this month, and Kroger rolled out GLP-1 savings programs in the spring.
Affordability and store resources
For self-pay patients, Publix said its pharmacists can help identify manufacturer savings programs and discount cards that may lower copays to as little as $149. In February, the Lakeland, Florida-based grocer began offering discount-card pricing on select GLP-1 therapies.
Publix also is tying the pharmacy program to in-store nutrition resources. Its “Create a lifestyle that lasts” brochure guides customers to protein and fiber options across departments and links to a digital weekly ad product page, while its green Better Choice shelf tags, developed by Publix registered dietitian nutritionists using the USDA Dietary Guidelines for Americans, 2025-2030, flag items higher in nutrients such as fiber and lower in saturated fat, added sodium and added sugar.
Publix is the largest employee-owned company in the U.S. and operates more than 1,400 stores across the Southeast.